Gottfried Konecny

8PUBLICATIONS
239CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 14, 2026
Homozygous Loss of Recombination Repair Genes and Poly ADP-Ribose Polymerase Inhibitor Benefit for Patients With Ovarian Cancer.

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Jan 13, 2025
ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer.

Lora Stojanovic, Rachel Abbotts, Kaushelendra Tripathi

|Sep 30, 2024
Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers.

Jamie E Medina, Akshaya V Annapragada, Pien Lof

|May 16, 2024
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial.

Joyce F Liu, Stéphanie Gaillard, Andrea E Wahner Hendrickson

|Oct 14, 2022
State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report.

Josee-Lyne Ethier, Katherine C Fuh, Rebecca Arend

Pageof 2

Frequent Collaborators

2 joint publications

James D Brenton

2 joint publications

Paul A Cohen

2 joint publications

Yee Leung

2 joint publications

Joshua Cohen